Literature DB >> 7745847

Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test.

I M al-Khatib1, I Dökmeci, M Fujiwara.   

Abstract

The effects of nomifensine (NOM) and methamphetamine (MA) on ambulation and rearing of rats in the open-field test were investigated. NOM and MA were injected i.p. into intact rats and nucleus accumbens (ACC)- and caudate-putamen (CP)-lesioned rats and infused into the ACC and CP. NOM (1-10 mg/kg, i.p.) and MA (1-5 mg/kg, i.p.) produced hyperactivity. However, NOM at 20 mg/kg, i.p. decreased the activity and induced repetitive head bobbing and squatting. Lesions of the ACC and CP increased open-field activity. However, lesion of the CP increased rearing more than lesion of the ACC. The increase in ambulation induced by NOM was inhibited by lesion of the ACC, whereas that induced by MA was inhibited by lesion of the CP. Although NOM (1-10 micrograms/2 microliters) and MA (0.5-10 micrograms/2 microliters) injections into the ACC and CP induced hyperactivity, the effect of NOM was greater after injection into the ACC, whereas the effect of MA was greater following injection into the CP. These results suggest that the ACC has a greater role in ambulation, while CP has a greater one in rearing. The present results, while they verified the significance of the ACC and CP in NOM- and MA-hyperactivity, also revealed a differential role of the ACC in NOM-hyperactivity and the CP in MA-hyperactivity.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745847     DOI: 10.1254/jjp.67.69

Source DB:  PubMed          Journal:  Jpn J Pharmacol        ISSN: 0021-5198


  7 in total

1.  Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Hiromi Asano; Ryuki Chatani; Sachiko Hayata; Hiroko Yokoyama; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2011-12-31       Impact factor: 3.252

2.  The stimulant effects of caffeine on locomotor behaviour in mice are mediated through its blockade of adenosine A(2A) receptors.

Authors:  M El Yacoubi; C Ledent; J F Ménard; M Parmentier; J Costentin; J M Vaugeois
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

3.  Effects of yokukansan on anxiety-like behavior in a rat model of cerebrovascular dementia.

Authors:  Ai Nogami; Yuri Sakata; Naoki Uchida; Kazuko Yamaguchi; Chihiro Kawasaki; Taro Shindo; Kaori Kubota; Shutaro Katsurabayashi; Kotaro Takasaki; Kenichi Mishima; Ryoji Nishimura; Michihiro Fujiwara; Katsunori Iwasaki
Journal:  J Nat Med       Date:  2010-12-09       Impact factor: 2.343

4.  Monosodium glutamate-associated alterations in open field, anxiety-related and conditioned place preference behaviours in mice.

Authors:  Olakunle James Onaolapo; Olaleye Samuel Aremu; Adejoke Yetunde Onaolapo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-03-29       Impact factor: 3.000

5.  Anandamide inhibits the DOI-induced head-twitch response in mice.

Authors:  Nobuaki Egashira; Kenichi Mishima; Tomoko Uchida; Nobuyoshi Hasebe; Hiroshi Nagai; Ai Mizuki; Katsunori Iwasaki; Hisanori Ishii; Ryoji Nishimura; Yukihiro Shoyama; Michihiro Fujiwara
Journal:  Psychopharmacology (Berl)       Date:  2003-10-30       Impact factor: 4.530

6.  Exogenous Testosterone, Aging, and Changes in Behavioral Response of Gonadally Intact Male Mice.

Authors:  Olakunle J Onaolapo; Adejoke Y Onaolapo; Tope A Omololu; Adedunke T Oludimu; Toluwalase Segun-Busari; Taofeeq Omoleke
Journal:  J Exp Neurosci       Date:  2016-05-02

7.  Distinct dose-dependent effects of methamphetamine on real-time dopamine transmission in the rat nucleus accumbens and behaviors.

Authors:  Rohan V Bhimani; Megan Vik; Ken T Wakabayashi; Caitlin Szalkowski; Caroline E Bass; Jinwoo Park
Journal:  J Neurochem       Date:  2021-07-28       Impact factor: 5.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.